BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4237949)

  • 1. [Value of an orotic acid-sorbitol combination in hepato-intestinal diseases. Point of view of a general practitioner].
    Lechat S; Pattin S; Vigne J
    Rev Corps Sante Armees Terre Mer Air; 1967 Apr; 8(2):259-66. PubMed ID: 4237949
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic testing of a mixture of orotic acid and sorbitol in adults with hepato-biliary diseases].
    Girard MM
    J Med Lyon; 1967 Sep; 48(127):1269-70. PubMed ID: 5619472
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of hepato-biliary diseases in children and adults by a drug composed of orotic acid and sorbitol].
    Cachin M; Alagille D
    Presse Med (1893); 1967 Apr; 75(17):859-60. PubMed ID: 6021371
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experimentation with Aïcamine in hepatic insufficiency].
    Négret JP
    Bord Med; 1972 Apr; 5(8):973-6. PubMed ID: 5053280
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience report on Hepavis].
    Menninger U; Menninger W
    Med Welt; 1980 Oct; 31(42):1519-21. PubMed ID: 7453534
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical studies on the liver-protective effect of 4-amino-5-imidazole carboxamide and orotic acid].
    Fehér VJ; Jakab L; Tenczer J; Szilvási I
    Dtsch Z Verdau Stoffwechselkr; 1977; 37(4):175-9. PubMed ID: 75788
    [No Abstract]   [Full Text] [Related]  

  • 7. [Betaine aspartate in the hepato-digestive domain].
    Cachin M; Pergola F
    Sem Ther; 1966 Oct; 42(8):423-4. PubMed ID: 5994378
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and biological study of the action of a new drug on icterus].
    Ribet A; Hardy M
    Sem Ther; 1967 Nov; 43(9):534-6. PubMed ID: 5623398
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of AICA orotate in hepatitis and cirrhosis].
    Chanoine F
    Acta Gastroenterol Belg; 1969; 32(4-5):383-95. PubMed ID: 4927897
    [No Abstract]   [Full Text] [Related]  

  • 10. [Observations on the treatment of chronic inflammatory liver diseases with the preparation Hepasteril B comp].
    Busse K; Otremba P
    Soins; 1970; 15(7):2608-13. PubMed ID: 4918343
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic value of the carboxylic thiazolidine acid and sorbitol combination in the treatment of dyspepsia of entero-hepato-biliary origin].
    Geoffroy H
    Sem Hop Ther; 1976 Feb; 52(2):93-7. PubMed ID: 982073
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic progress in chronic liver diseases].
    Wildhirt E
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(2):207-8. PubMed ID: 4894834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical and biological effectiveness of citiolone and importance of its contribution in hepatic therapeutics].
    Duché G
    Therapeutique; 1970 Dec; 46(10):1037-41. PubMed ID: 5511931
    [No Abstract]   [Full Text] [Related]  

  • 14. Preliminary observations of d-penicillamine therapy in acute alcoholic liver disease.
    Resnick RH; Boitnott J; Iber FL; Makopour H; Cerda JJ
    Digestion; 1974; 11(3-4):257-65. PubMed ID: 4615021
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glucocorticoids in chronic liver diseases].
    Maier KP; Talke H; Gerok W
    Dtsch Med Wochenschr; 1975 Mar; 100(11):560-3. PubMed ID: 1116441
    [No Abstract]   [Full Text] [Related]  

  • 16. [Purine and orotic acid therapy of chronic hepatitis and liver cirrhosis].
    ROSSING P; EBERHARD H; BRANDENBURG W
    Dtsch Med J; 1956 Apr; 7(8):201-4. PubMed ID: 13344173
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutical analysis of a sorbitol plus fentropilium compound on various clinical forms of liver diseases].
    Ferraz WG
    Hospital (Rio J); 1967 May; 71(5):1403-12. PubMed ID: 5303472
    [No Abstract]   [Full Text] [Related]  

  • 18. [Trial of LL 650 in various hepatic diseases].
    Savoye B; Dietsch R; Chapuy M; Girard M
    J Med Lyon; 1972 May; 53(228):675-6 passim. PubMed ID: 5084113
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with the oral liver-therapeutic agent Hepavis].
    Bayazid A; Gerhard W
    Med Welt; 1976 Nov; 27(46):2248-9. PubMed ID: 794616
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment with Hepavis, a new cholerectically-active hepaticum. Experiences from an internal medicine profemoral practice].
    Stuchlik S
    Med Monatsschr; 1977 Nov; 31(11):524-6. PubMed ID: 927326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.